{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:29:32Z","timestamp":1790368172666,"version":"4.1.0"},"reference-count":33,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: The association of intravenous prostacyclin therapy, essential for improving prognosis and survival in pulmonary arterial hypertension (PAH), with gastric epithelial neoplasms is uncertain. This study aimed to analyze the clinicopathologic features of gastric neoplasms in patients with PAH undergoing continuous intravenous prostacyclin therapy. Methods: We screened the registry of patients with pulmonary hypertension who visited the NHO Okayama Medical Center. Of the patients with PAH managed between January 2003 and December 2022, those who underwent esophagogastroduodenoscopy (EGD) were assessed for gastric neoplasms. Their clinical, endoscopic, and histopathological data were reviewed. Results: Among the 186 patients with PAH, 56 underwent EGD, revealing 4 patients (aged 37\u201350 years) with gastric epithelial neoplastic lesions. All four patients received continuous intravenous prostacyclin therapy for a median of 151 months. Of the 98 patients who received prostacyclin, 28 patients underwent EGD; the incidence of gastric epithelial neoplasms was 4.1% (4\/98) and the endoscopic detection rate was 14.3% (4\/28). All patients had multiple tumors against a background of hypertrophic gastropathy (histologically being foveolar epithelial hyperplasia), with shared features of distal location, elevated morphology, and absent submucosal invasion. However, lymph node metastasis was observed in one lesion. By immunohistochemistry, the tumors exhibited gastric-predominant mucus phenotype and were managed by surgical or endoscopic resection without recurrence. Conclusions: The consistent clinicopathologic features of these cases suggest an association between continuous intravenous prostacyclin therapy and the development of hypertrophic gastropathy with potential progression to gastric epithelial neoplasia. Further prospective clinical trials are warranted to ensure safer prostacyclin use.<\/jats:p>","DOI":"10.3390\/jcm14030791","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T07:54:08Z","timestamp":1738050848000},"page":"791","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gastric Epithelial Neoplasms in Patients with Pulmonary Arterial Hypertension Receiving Continuous Intravenous Prostacyclin Therapy"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8564-5080","authenticated-orcid":false,"given":"Tomohiko","family":"Mannami","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Shimokawahara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyosuke","family":"Horikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Shinno","sequence":"additional","affiliation":[{"name":"Department of Pathology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Umekawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Sakaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin\u2019ichi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Nozaki","sequence":"additional","affiliation":[{"name":"Department of Surgery, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, NHO Okayama Medical Center, Okayama 701-1192, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2401324","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.01.024","article-title":"Pulmonary arterial hypertension","volume":"51","author":"Chin","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ad\u00e3o, R., Perez-Vizcaino, F., Redwan, B., and Br\u00e1s-Silva, C. (2024). Editorial: Therapeutics in pulmonary arterial hypertension. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1463305"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/17425250802622962","article-title":"Epoprostenol in pulmonary arterial hypertension","volume":"5","author":"Jacobs","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jjcc.2022.04.003","article-title":"Outcome of mean pulmonary arterial pressure-based intensive treatment for patients with pulmonary arterial hypertension","volume":"80","author":"Sugiyama","year":"2022","journal-title":"J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ahj.2013.08.007","article-title":"EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension","volume":"167","author":"Sitbon","year":"2014","journal-title":"Am. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1253\/circj.CJ-18-0349","article-title":"Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients with Pulmonary Arterial Hypertension","volume":"82","author":"Miura","year":"2018","journal-title":"Circ. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/1097-0142(19900801)66:3<587::AID-CNCR2820660330>3.0.CO;2-J","article-title":"Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension","volume":"66","author":"Illes","year":"1990","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2045894019851000","DOI":"10.1177\/2045894019851000","article-title":"Pulmonary tumor thrombotic microangiopathy: A systematic review","volume":"9","author":"Godbole","year":"2019","journal-title":"Pulm. Circ."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1183\/09031936.00175909","article-title":"Pulmonary hypertension in patients with chronic myeloproliferative disorders","volume":"35","author":"Adir","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.3390\/cimb46080496","article-title":"Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications-A Narrative Review","volume":"46","author":"Todor","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-022-01331-8","article-title":"Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)","volume":"26","author":"Association","year":"2023","journal-title":"Gastric Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ajg.2014.425","article-title":"Indications and Techniques for Endoscopic Submucosal Dissection","volume":"110","author":"Bhatt","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000515354","article-title":"Current Endoscopic Resection Techniques for Gastrointestinal Lesions: Endoscopic Mucosal Resection, Submucosal Dissection, and Full-Thickness Resection","volume":"37","author":"Hoffman","year":"2021","journal-title":"Visc. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ijc.1460","article-title":"MUC gene expression and histogenesis of adenocarcinoma of the stomach","volume":"94","author":"Tsukashita","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_23","unstructured":"National Cancer Center, Japan (2024, November 30). Cancer Statistics in Japan. National Cancer Registry (Ministry of Health, Labour and Welfare), tabulated by Cancer Information Service. Available online: https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/en.html."},{"key":"ref_24","unstructured":"Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2024). Global Cancer Observatory: Cancer Today, International Agency for Research on Cancer. Available online: https:\/\/gco.iarc.who.int\/today\/en\/fact-sheets-cancers."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0016-5085(90)90292-9","article-title":"Clinical and morphological characteristics of early gastric cancer. A case-control study","volume":"98","author":"Eckardt","year":"1990","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.41.2.142","article-title":"Early gastric cancer in Europe","volume":"41","author":"Everett","year":"1997","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM200012073432305","article-title":"Treatment of Menetrier\u2019s disease with a monoclonal antibody against the epidermal growth factor receptor","volume":"343","author":"Burdick","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2036.1995.tb00377.x","article-title":"Review article: New insights into prostaglandins and mucosal defence","volume":"9","author":"Wallace","year":"1995","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jgh.12767","article-title":"Importance of cyclooxygenase-1\/prostacyclin in modulating gastric mucosal integrity under stress conditions","volume":"29","author":"Amagase","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"G519","DOI":"10.1152\/ajpgi.00113.2005","article-title":"Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice","volume":"290","author":"Kanda","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cgh.2020.03.017","article-title":"Survival Times of Patients with Menetrier\u2019s Disease and Risk of Gastric Cancer","volume":"19","author":"Almazar","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10120-017-0704-y","article-title":"A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): The Japan Clinical Oncology Group study (JCOG0607)","volume":"21","author":"Hasuike","year":"2018","journal-title":"Gastric Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/j.gastro.2018.04.026","article-title":"Endoscopic Screening in Asian Countries Is Associated with Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review","volume":"155","author":"Zhang","year":"2018","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/791\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:36:11Z","timestamp":1759919771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/3\/791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14030791"],"URL":"https:\/\/doi.org\/10.3390\/jcm14030791","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]}}}